Report Categories Report Categories

Report Categories

industry Category

All

Total: 3 records, 1 pages

Global Neuromyelitis Optica Drug Supply, Demand and Key Producers, 2024-2030

date 10 Feb 2024

date Pharma & Healthcare

new_biaoQian Neuromyelitis Optica Drug

The global Neuromyelitis Optica Drug market size is expected to reach $ 59 million by 2030, rising at a market growth of 2.9% CAGR during the forecast period (2024-2030).

USD4480.00

Add To Cart

Add To Cart

Global Neuromyelitis Optica Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

new_biaoQian Neuromyelitis Optica Drug

According to our (Global Info Research) latest study, the global Neuromyelitis Optica Drug market size was valued at USD 48 million in 2023 and is forecast to a readjusted size of USD 59 million by 2030 with a CAGR of 2.9% during review period.

USD3480.00

Add To Cart

Add To Cart

Global Neuromyelitis Optica Drug Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Pharma & Healthcare

new_biaoQian Neuromyelitis Optica Drug

Neuromyelitis optica (NMO) is an uncommon disease syndrome of the central nervous system (CNS) that affects the optic nerves and spinal cord. Individuals with NMO develop optic neuritis, which causes pain in the eye and vision loss, and transverse myelitis, which causes weakness, numbness, and sometimes paralysis of the arms and legs, along with sensory disturbances and loss of bladder and bowel control. NMO leads to loss of myelin, which is a fatty substance that surrounds nerve fibers and helps nerve signals, move from cell to cell. The syndrome can also damage nerve fibers and leave areas of broken-down tissue. In the disease process of NMO, for reasons that aren't yet clear, immune system cells and antibodies attack and destroy myelin cells in the optic nerves and the spinal cord.

USD3480.00

Add To Cart

Add To Cart

industry 10 Feb 2024

industry Pharma & Healthcare

new_biaoQian Neuromyelitis Optica Drug

The global Neuromyelitis Optica Drug market size is expected to reach $ 59 million by 2030, rising at a market growth of 2.9% CAGR during the forecast period (2024-2030).

USD4480.00

addToCart

Add To Cart

industry 02 Jan 2024

industry Pharma & Healthcare

new_biaoQian Neuromyelitis Optica Drug

According to our (Global Info Research) latest study, the global Neuromyelitis Optica Drug market size was valued at USD 48 million in 2023 and is forecast to a readjusted size of USD 59 million by 2030 with a CAGR of 2.9% during review period.

USD3480.00

addToCart

Add To Cart

industry 18 Mar 2023

industry Pharma & Healthcare

new_biaoQian Neuromyelitis Optica Drug

Neuromyelitis optica (NMO) is an uncommon disease syndrome of the central nervous system (CNS) that affects the optic nerves and spinal cord. Individuals with NMO develop optic neuritis, which causes pain in the eye and vision loss, and transverse myelitis, which causes weakness, numbness, and sometimes paralysis of the arms and legs, along with sensory disturbances and loss of bladder and bowel control. NMO leads to loss of myelin, which is a fatty substance that surrounds nerve fibers and helps nerve signals, move from cell to cell. The syndrome can also damage nerve fibers and leave areas of broken-down tissue. In the disease process of NMO, for reasons that aren't yet clear, immune system cells and antibodies attack and destroy myelin cells in the optic nerves and the spinal cord.

USD3480.00

addToCart

Add To Cart